This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ac Immune Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Véronique Dehlinger
Introduction
Véronique Dehlinger is a notable inventor based in Morges, Switzerland. She has made significant contributions to the field of medical science, particularly in the modulation of the NLRP3 inflammasome pathway. Her work focuses on developing novel compounds that can potentially treat various diseases and disorders.
Latest Patents
Véronique Dehlinger holds a patent for "Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway." This invention relates to new compounds designed for the treatment, alleviation, or prevention of diseases that respond to the modulation of the NLRP3 inflammasome pathway. The compounds are particularly effective in decreasing levels of IL-1 beta and/or IL-18, which are crucial in inflammatory responses.
Career Highlights
Véronique is associated with Ac Immune SA, a company that focuses on developing innovative therapies for neurodegenerative diseases. Her expertise in the field has led to advancements in understanding and treating conditions linked to the NLRP3 inflammasome.
Conclusion
Véronique Dehlinger is a pioneering inventor whose work in modulating the NLRP3 inflammasome pathway holds promise for future medical treatments. Her contributions continue to impact the field of medical science positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile